If SpaceX Stock Falls Below $135, Here's the Move I'd Make

SpaceX shares have fallen to $145 from a June 16 record of $211.39, close to the $135 IPO price, amid rising yields, lockup expirations and concerns about valuation and operating losses. In the first half of 2026, Starlink’s $2.84 billion operating profit was outweighed by losses of $1.20 billion in space and $3.73 billion in AI; shares at $145 imply a $2.0 trillion market cap, or 45 times this year’s sales. Analysts expect Q3 revenue to rise 65% sequentially, but the article’s author would avoid buying just below the IPO price and would consider the stock only after a substantially larger decline.

Analysis

The key issue is not whether SpaceX can post rapid sequential growth, but whether Starlink can fund the capital demands of the launch and AI businesses without persistent cash burn or value-destructive cross-subsidies. Consolidated revenue growth can therefore mask worsening economics: track segment operating losses alongside capex, cash flow, and the incremental cost of converting AI contracts and satellite expansion into durable returns.

Near term, the Oct. 20 report is a binary positioning event. A headline beat may not support the stock if backlog quality, monetization milestones, or funding needs disappoint. The thin IPO allocation and continuing lockup releases also weaken price discovery; insider supply can amplify a modest miss, particularly while higher yields pressure long-duration valuations. Over 6–18 months, direct-to-cell could broaden Starlink’s addressable market, but spectrum alone does not establish deployment economics or regulatory clearance, and could alter relationships with terrestrial carriers.

Contrarian point: the selloff does not itself make the shares cheap. The enormous valuation still embeds substantial execution, while a sharp drawdown could eventually improve entry risk if losses narrow and cash generation becomes clearer. Falsifiers to the cautious view are sustained improvement in consolidated cash flow, shrinking AI/space operating losses, and evidence of backlog conversion and direct-to-cell commercialization; worsening losses or continued insider selling would reinforce it.

Key Decisions for Investors

• Do not treat a dip just below the IPO price as a valuation signal. Avoid initiating a core long before the earnings reaction and lockup-related supply are better understood.
• For event-oriented exposure, consider only defined-risk downside structures after checking option liquidity and implied volatility; a disappointing report could be compounded by insider supply, while a growth or monetization surprise could cause a sharp squeeze.
• After the report, monitor segment losses, capex and cash flow, backlog conversion, and specific AI and direct-to-cell monetization milestones—not sequential revenue growth alone. Reassess a speculative long only if these measures improve together.
• The cautious thesis is invalidated by sustained cash-flow improvement and narrowing losses despite expansion; it is strengthened by widening segment losses, weaker backlog conversion, or lockup selling that persists after the event.